Blockade of VEGFR 2 and Not VEGFR 1 Can Limit Diet-Induced Fat Tissue Expansion : Role of Local versus Bone Marrow-Derived Endothelial Cells

Background: We investigated if new vessel formation in fat involves the contribution of local tissue-derived endothelial cells (i.e., angiogenesis) or bone marrow-derived cells (BMDCs, i.e. vasculogenesis) and if antiangiogenic treatment by blockade of vascular endothelial growth factor (VEGF) receptors can prevent diet-induced obesity (DIO). Methodology/Principal Findings: We performed restorative bone marrow transplantation into wild-type mice using transgenic mice expressing green fluorescent protein (GFP) constitutively (driven by b-actin promoter) or selectively in endothelial cells (under Tie2 promoter activation) as donors. The presence of donor BMDCs in recipient mice was investigated in fat tissue vessels after DIO using in vivo and ex vivo fluorescence microscopy. We investigated the roles of VEGF receptors 1 and 2 (VEGFR1/VEGFR2) by inducing DIO in mice and treating them with blocking monoclonal antibodies. We found only marginal (less than 1%) incorporation of BMDCs in fat vessels during DIO. When angiogenesis was inhibited by blocking VEGFR2 in mice with DIO, treated mice had significantly lower body weights than control animals. In contrast, blocking VEGFR1 had no discernable effect on the weight gain during DIO. Conclusions/Significance: Formation of new vessels in fat tissues during DIO is largely due to angiogenesis rather than de novo vasculogenesis. Antiangiogenic treatment by blockade of VEGFR2 but not VEGFR1 may limit adipose tissue expansion. Citation: Tam J, Duda DG, Perentes JY, Quadri RS, Fukumura D, et al. (2009) Blockade of VEGFR2 and Not VEGFR1 Can Limit Diet-Induced Fat Tissue Expansion: Role of Local versus Bone Marrow-Derived Endothelial Cells. PLoS ONE 4(3): e4974. doi:10.1371/journal.pone.0004974 Editor: Thorkild I. A. Sorensen, Institute of Preventive Medicine, Denmark Received December 23, 2008; Accepted February 19, 2009; Published March 31, 2009 Copyright: 2009 Tam et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: This study was partially supported by National Institutes of Health grants P01CA80124, R01CA96915, R01CA115767, R01CA85140, and R01CA126642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. * E-mail: dai@steele.mgh.harvard.edu (DF); jain@steele.mgh.harvard.edu (RKJ) . These authors contributed equally to this work.

[1]  Kyongbum Lee,et al.  Enhanced proliferation of human umbilical vein endothelial cells and differentiation of 3T3-L1 adipocytes in coculture. , 2009, Tissue engineering. Part A.

[2]  S. Msika,et al.  Angiogenesis Associated With Visceral and Subcutaneous Adipose Tissue in Severe Human Obesity , 2008, Diabetes.

[3]  S. Corvera,et al.  Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. , 2008, American journal of physiology. Endocrinology and metabolism.

[4]  H. Lijnen Angiogenesis and obesity. , 2008, Cardiovascular research.

[5]  R. Hammer,et al.  Vasculature White Fat Progenitor Cells Reside in the Adipose , 2008 .

[6]  Yihai Cao Angiogenesis modulates adipogenesis and obesity. , 2007, The Journal of clinical investigation.

[7]  T. Kadowaki,et al.  Adipogenesis in Obesity Requires Close Interplay Between Differentiating Adipocytes, Stromal Cells, and Blood Vessels , 2007, Diabetes.

[8]  M. Matsuda,et al.  Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation , 2007, Diabetes.

[9]  M. Shibuya Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. , 2006, Journal of biochemistry and molecular biology.

[10]  Peter Carmeliet,et al.  VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  R. Jain,et al.  Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. , 2006, Blood.

[12]  Betty Y. Y. Tam,et al.  VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. , 2006, American journal of physiology. Heart and circulatory physiology.

[13]  P. Carmeliet,et al.  Impaired adipose tissue development in mice with inactivation of placental growth factor function. , 2006, Diabetes.

[14]  P. Sucharda,et al.  Angiogenic factors are elevated in overweight and obese individuals , 2005, International Journal of Obesity.

[15]  R. Lijnen,et al.  Modulation of angiogenesis during adipose tissue development in murine models of obesity. , 2005, Endocrinology.

[16]  K. Yagui,et al.  Roles of degree of fat deposition and its localization on VEGF expression in adipocytes. , 2005, American journal of physiology. Endocrinology and metabolism.

[17]  M. F. Booth,et al.  Differential Transplantability of Tumor-Associated Stromal Cells , 2004, Cancer Research.

[18]  Napoleone Ferrara,et al.  Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.

[19]  Yihai Cao,et al.  Angiogenesis Inhibitor, TNP-470, Prevents Diet-Induced and Genetic Obesity in Mice , 2004, Circulation research.

[20]  Wadih Arap,et al.  Reversal of obesity by targeted ablation of adipose tissue , 2004, Nature Medicine.

[21]  R. L. Richardson,et al.  Adipose tissue angiogenesis. , 2004, Journal of animal science.

[22]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[23]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[24]  R. Jain,et al.  Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis , 2003, Circulation research.

[25]  H. Bujo,et al.  Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects , 2003, Diabetologia.

[26]  R. Jain,et al.  Responses to antiangiogenesis treatment of spontaneous autochthonous tumors and their isografts. , 2003, Cancer research.

[27]  Koichi Hattori,et al.  Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? , 2002, Nature Reviews Cancer.

[28]  B. Lowell,et al.  Adipose tissue mass can be regulated through the vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Rafii,et al.  Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment , 2002, Nature Medicine.

[30]  I. Castan-Laurell,et al.  Decreased resistin expression in mice with different sensitivities to a high-fat diet. , 2001, Biochemical and biophysical research communications.

[31]  Neil D. Theise,et al.  Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.

[32]  R. B. Campbell,et al.  In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy , 2001, Nature Medicine.

[33]  M. Olive,et al.  Life without white fat: a transgenic mouse. , 1998, Genes & development.

[34]  T. Rosengart,et al.  Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. , 1997, The Journal of surgical research.

[35]  B. Spiegelman,et al.  Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. , 1992, The Journal of biological chemistry.